These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29678950)

  • 1. Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.
    Heredia JD; Park J; Brubaker RJ; Szymanski SK; Gill KS; Procko E
    J Immunol; 2018 Jun; 200(11):3825-3839. PubMed ID: 29678950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4.
    Antonsson L; Boketoft A; Garzino-Demo A; Olde B; Owman C
    AIDS; 2003 Dec; 17(18):2571-9. PubMed ID: 14685051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding.
    Basmaciogullari S; Babcock GJ; Van Ryk D; Wojtowicz W; Sodroski J
    J Virol; 2002 Nov; 76(21):10791-800. PubMed ID: 12368322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
    J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokines CCL5 and CXCL12 exhibit high-affinity binding to N-terminal peptides of the non-cognate receptors CXCR4 and CCR5, respectively.
    Kessler N; Akabayov SR; Cohen LS; Scherf T; Naider F; Anglister J
    FEBS J; 2024 Feb; 291(3):458-476. PubMed ID: 37997026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
    Brelot A; Heveker N; Montes M; Alizon M
    J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
    Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF;
    Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.
    Meehan CJ; Hedge JA; Robertson DL; McCormack GP; Travers SA
    J Med Virol; 2010 Dec; 82(12):2004-12. PubMed ID: 20981786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.
    Liu QH; Williams DA; McManus C; Baribaud F; Doms RW; Schols D; De Clercq E; Kotlikoff MI; Collman RG; Freedman BD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4832-7. PubMed ID: 10758170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple mechanisms of self-association of chemokine receptors CXCR4 and CCR5 demonstrated by deep mutagenesis.
    Gill KS; Mehta K; Heredia JD; Krishnamurthy VV; Zhang K; Procko E
    J Biol Chem; 2023 Oct; 299(10):105229. PubMed ID: 37690681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.
    Wescott MP; Kufareva I; Paes C; Goodman JR; Thaker Y; Puffer BA; Berdougo E; Rucker JB; Handel TM; Doranz BJ
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9928-33. PubMed ID: 27543332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.
    Deng X; Ueda H; Su SB; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
    Blood; 1999 Aug; 94(4):1165-73. PubMed ID: 10438703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
    Schwalbe B; Schreiber M
    PLoS One; 2015; 10(3):e0119879. PubMed ID: 25785610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
    Pastore C; Nedellec R; Ramos A; Pontow S; Ratner L; Mosier DE
    J Virol; 2006 Jan; 80(2):750-8. PubMed ID: 16378977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.